Andrea Liane Christianson, CNM | |
411 Durham Rd, Birth And Beyond, Madison, CT 06443-2041 | |
(203) 613-8884 | |
(203) 613-8886 |
Full Name | Andrea Liane Christianson |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 411 Durham Rd, Madison, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700889920 | NPI | - | NPPES |
4094445 | Other | TN | BLUE CROSS BLUE SHIELD |
008056418 | Medicaid | CT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | 391 (Connecticut) | Primary |
367A00000X | Advanced Practice Midwife | CMW00139 (Rhode Island) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Andrea Liane Christianson, CNM 411 Durham Rd, Birth And Beyond, Madison, CT 06443-2041 Ph: (203) 613-8884 | Andrea Liane Christianson, CNM 411 Durham Rd, Birth And Beyond, Madison, CT 06443-2041 Ph: (203) 613-8884 |
News Archive
Financial strain and competing priorities at home may contribute to the greater number of hospital readmissions of children with asthma from single-parent homes compared to dual-parent households, according to a new study presented at the American College of Allergy, Asthma and Immunology Annual Meeting in Boston, Nov. 3-8.
Alleviating food insecurity is often seen as one of the fundamental roles a country should fulfill. In some cases, this is encapsulated into a constitutionally formalized "right to food".
Researchers have found evidence that the gastrointestinal tract plays a role in the inflammatory pathology of bipolar disorder, suggesting the need to consider dietary modification and anti-inflammatory treatment for some patients.
Women with problem transvaginal mesh surgery must hurry to file their claims, according to a major public information website for mesh victims, or risk not participating in current billion-dollar court settlements.
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today results from its Phase 2a clinical trial for its ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes. The trial was conducted under a United States Food and Drug Administration IND (Investigational New Drug) protocol. The Phase 2a study met all primary and secondary endpoints.
› Verified 4 days ago
Lillian Siegel, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 411 Durham Rd, Birth & Beyond, Madison, CT 06443 Phone: 203-318-8884 Fax: 203-318-8886 |